Fig. 1 · Structure

Documents & Downloads

Paclitaxel octadecanedioate

Anti-tumor Agent

Paclitaxel octadecanedioate is an anti-tumor agent formed by the conjugation of Paclitaxel to 1,18-octadecanedioic acid. This compound exhibits significant cytotoxicity against various cancer cell lines, including HT-1080, PANC-1, HT-29, and HeLa, with IC50 values of 12 nM, 2.48 nM, 8.62 nM, and 64.42 nM, respectively. Its formulation with human serum albumin enhances its potential for targeted cancer therapy applications.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 2089211-45-8
Applications Anti-tumor Agent
Formula C65H83NO17
Molecular Weight 1150.35
SMILES
CC(O[C@]12[C@@]3([H])[C@@H]([C@]4(C(C)(C([C@H](C([C@@]3([C@H](C[C@@]1([H])OC2)O)C)=O)OC(C)=O)=C([C@H](C4)OC([C@H](OC(CCCCCCCCCCCCCCCCC(O)=O)=O)[C@H](C5=CC=CC=C5)NC(C6=CC=CC=C6)=O)=O)C)C)O)OC(C7=CC=CC=C7)=O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...